Lung Neuroendocrine Tumor G2 — Trials

Lung Neuroendocrine Tumor G2 — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03879694	Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors	completed	Phase 1	19	Roswell Park Cancer InstituteOTHER	1	Feb 6, 2026	clinicaltrials

Data updated 22 days agoSource updated Feb 6, 2026source: clinicaltrials